The action of RFamide neuropeptides on molluscs, with special reference to the gastropods Buccinum undatum and Busycon canaliculatum.
The ever-growing RFamide neuropeptide superfamily has members in all animal phyla. Their effects in molluscs, on both smooth and cardiac muscle as well as on neurons, has been studied in detail. These neuropeptides exert a variety of functions: excitatory, inhibitory or even biphasic. Firstly, the literature on the excitatory effect of the RFamide neuropeptides on molluscan muscle and neurons has been reviewed, with greater emphasis and examples from the gastropods Buccinum undatum and Busycon canaliculatum. The peptides seem to be potent activators of contraction, sometimes generating slow tonic force and other times twitch activity. Secondly, the literature on the inhibitory effect of the superfamily has been reviewed. These peptides can exert an inhibitory effect, hyperpolarizing the cells rather than depolarizing them. Thirdly, the neuropeptides may play a variety of other roles, such as contributing to the regulation or maturation process of the animals. There have been cases recorded of RFamide neuropeptides acting as potent venoms in members of the Conus sp. The pathway of action of these multiple roles, their interaction with the parent neurotransmitters acetylcholine and serotonin, as well as the calcium dependency of the RFamide neuropeptides has been discussed, again with special reference to the above mentioned gastropods. A better understanding of the mode of action, the effects, and the importance of the RFamide neuropeptides on molluscan physiology and pharmacology has been attempted by reviewing the existing literature, recognizing the importance of the RFamide neuropeptide actions on molluscs.
Moulis
Alexander
A
Department of Biological Sciences, Institute of Environmental and Natural Sciences, Lancaster University, 103 Priamou St., 16673 Voula, Athens, Greece. alexmoulis@hotmail.com
D000109:Acetylcholine / Q000502:physiology; D000818:Animals; D002118:Calcium / Q000502:physiology; D004347:Drug Interactions; D049851:Gastropoda / Q000187:drug effects*; D015640:Ion Channel Gating / Q000187:drug effects; D008958:Models, Molecular; D009119:Muscle Contraction / Q000187:drug effects; D009130:Muscle, Smooth / Q000187:drug effects; D009479:Neuropeptides / Q000494:pharmacology*; D009842:Oligopeptides / Q000494:pharmacology; D012701:Serotonin / Q000502:physiology; D015222:Sodium Channels / Q000187:drug effects
D009479:Neuropeptides; D009842:Oligopeptides; D015222:Sodium Channels; D012701:Serotonin; C058047:arginylphenylalaninamide; C066148:phenylalanyl-leucyl-arginyl phenylalaninamide; D000109:Acetylcholine; D002118:Calcium